CGA
ALXN

Crescent Grove Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Crescent Grove Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,500
Closed -$276K – 296
2021
Q2 		$276K Hold
1,500
– – 0.03% 208
2021
Q1 		$229K Hold
1,500
– – 0.03% 189
2020
Q4 		$234K Buy
+1,500
New +$234K 0.03% 164